Jiuzhou Da Pharmacy 2022 Treasury losses narrowed 61.8% year -on -year

On July 28, 2022, the US -listed company Jiuzhou Pharmacy (CJJD.US) announced the performance of fiscal year for 2022 as of March 31, 2022.

In fiscal 2022, the company's total revenue was US $ 164 million, an increase of 23.5%year -on -year; gross profit of US $ 36.52 million, an increase of 24.9%year -on -year; a net loss of 3.2 million US dollars, a year -on -year narrowing of 61.8%; a loss per share of $ 0.92, the same period last year was the same period last year was the same period last year.Loss is $ 2.39.

During the period, the revenue of retail pharmacies was US $ 84.23 million, a year -on -year increase of 10.7%; online pharmacy revenue was US $ 30.22 million, an increase of 34.4%year -on -year; the wholesale business revenue was 49.94 million US dollars, an increase of 44.6%year -on -year.

The main reason for the growth of online pharmacy revenue is to increase the sales of commercial insurance customers through the company's official website and the growth of centers for sales prescriptions such as Tmall and other e -commerce platforms.

- END -